Vir Biotechnology



Vir is focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases.

Antonio Lanzavecchia
SVP and Senior Research Fellow
Bolyn Hubby
Chief Corporate Affairs Officer
Herbert Virgin
EVP of Research and Chief Scientific Officer
Howard Horn
Chief Financial Officer
Irene Pleasure, J.D., Ph.D.
VP of Intellectual Property and Associate General Counsel
Lynne Krummen
SVP of Regulatory and Development Program Leadership and Management
Phil Pang
Chief Medical Officer
Steven Rice
Chief Administrative Officer
Aine Hanly
Chief Technology Officer

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.